On 22 October 2020, FDA approved a new drug application (NDA) for Veklury (remdesivir), a drug indicated for adults and pediatric patients […]
Blog Archive
0
Update on COVID-19 vaccines suspected adverse reactions (63) in Switzerland
On 05 February 2021, Swissmedic has evaluated 63 reports of suspected adverse drug reactions (ADR) to COVID-19 vaccinations in Switzerland (in collaboration […]
0
Update on EU Additional monitoring Medicines (January 2021)
The list of medicinal products subject to additional monitoring includes medicinal products authorised in the European Union (EU) which are subject to […]
0
Safety signal (Risk of acute adrenal insufficiency) Hydrocortisone
European Medicines Agency (EMA) has published Direct healthcare professional communications (DHPC) regarding the Risk of acute adrenal insufficiency when switching from crushed […]
1
Drug Safety Alerts UK MHRA (November 2020)
Drug Safety Alerts UK MHRA (November 2020): UK Medicines & Healthcare products Regulatory Agency (MHRA) has provided 8 safety letters and 06 […]
